A well-placed biotech investor says U.S. policies are straining life sciences startups — and more disruption is coming.

From precision medicine to food safety, biotech instrumentation is quickly becoming one of the most influential forces across modern sectors.

Biotech companies are using a new set of artificial intelligence products to hasten drug discovery and other scientific research, and they’re energized by the Food and Drug Administration’s ...

BURLINGTON - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, confirmed Neoclease as the winner of the 2025 North ...